Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.29 -0.35 (-1.88%)
As of: Sep 30, 2026 · 12:17 PM EDT

Sarepta Therapeutics (SRPT) Capital Expenditures (2010 - 2026)

Updated

Sarepta Therapeutics (SRPT) recorded Capital Expenditures of $555,000 in Q2 2026, down 98.3% from $31.8 million a year earlier and down 73.3% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Capital Expenditures (2010 - 2026) Analysis & Trends

On a TTM basis, Sarepta Therapeutics' Capital Expenditures came in at $29.16 million as of Jun 30, 2026, down 80.7% year-over-year; for FY2025, it was $101.97 million, down 25.5% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $136.96 million in FY2024 (+80.0%), $76.11 million in FY2023 (+146.9%), $30.82 million in FY2022 (-19.9%) and $38.49 million in FY2021 (-53.2%).
  • The Q2 2026 figure is the lowest quarterly Capital Expenditures since Q2 2016.
  • On a year-over-year basis, Capital Expenditures has declined for four consecutive quarters, with an average decline of 19.2% over the last eight quarters.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 261.0% in Q4 2022, against a decline of 98.3% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.08 million (Q1 2026), $3.59 million (Q4 2025) and $22.93 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Sarepta Therapeutics 1.99 Bn -1.25 Bn 251.87 Mn 555,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 555,000.00
Mar 31, 2026 2.08 Mn
Dec 31, 2025 3.59 Mn
Sep 30, 2025 22.93 Mn
Jun 30, 2025 31.80 Mn
Mar 31, 2025 43.65 Mn
Dec 31, 2024 38.08 Mn
Sep 30, 2024 37.26 Mn
Jun 30, 2024 29.17 Mn
Mar 31, 2024 32.44 Mn
Dec 31, 2023 19.04 Mn
Sep 30, 2023 29.67 Mn
Jun 30, 2023 17.91 Mn
Mar 31, 2023 9.49 Mn
Dec 31, 2022 7.96 Mn
Sep 30, 2022 8.23 Mn
Jun 30, 2022 9.08 Mn
Mar 31, 2022 5.55 Mn
Dec 31, 2021 2.21 Mn
Sep 30, 2021 9.24 Mn
API Access

Sarepta Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SRPT&period=max&api_key=YOUR_API_KEY